• POST-TEST QUESTIONNAIRE

    Saturday, September 20th, 2025 | Huntington Beach, CA

  • Update on CD19-Targeted CAR T-cell Therapy to Treat Severe Refractory Systemic Lupus Erythematosus (SLE)

  • 1. Which of the following statements is false?*
  • 2. An advantage of CAR T-cell treatment in systemic lupus erythematosus (SLE) is:*
  • 3. A major disadvantage of autologous CAR T-cell treatment in SLE is:*

  • EVALUATION FORM

  • AcademicCME appreciates your opinions to help assist us in the evaluation of the effectiveness of this activity and to identify your ongoing educational needs. Learners must complete this evaluation form to receive acknowledgement for completing this activity.

  • What is your license?*
  • If PharmD, DOB
     - -
    2 digit month, 2 digit day, 4 digit year
  • What is your specialty?*
  • What is your practice setting?*

  • Please rate the extent to which this activity met the following objectives:

  • Learning Objectives
    Rows
  • Please provide us with feedback regarding your experience at the activity:
    Rows
  • Please rate the faculty on their overall teaching ability:
    Rows
  • Do you feel this activity was fair balanced and free of commercial bias?
  • This educational activity will result in a change in my role as a healthcare team member.
  • Date
     - -
    2 digit month, 2 digit day, 4 digit year

  • Attestation: This activity is certified for a maximum of 1.0 AMA PRA Category 1 Credits™.

  • Should be Empty: